EA201691232A1 - METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS - Google Patents

METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS

Info

Publication number
EA201691232A1
EA201691232A1 EA201691232A EA201691232A EA201691232A1 EA 201691232 A1 EA201691232 A1 EA 201691232A1 EA 201691232 A EA201691232 A EA 201691232A EA 201691232 A EA201691232 A EA 201691232A EA 201691232 A1 EA201691232 A1 EA 201691232A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
methods
disease
disorders
Prior art date
Application number
EA201691232A
Other languages
Russian (ru)
Inventor
И Ши
Роберт Нейджел
Original Assignee
Томас Джефферсон Юниверсити
Роуэн Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Томас Джефферсон Юниверсити, Роуэн Юниверсити filed Critical Томас Джефферсон Юниверсити
Priority to EA201691232A priority Critical patent/EA201691232A1/en
Publication of EA201691232A1 publication Critical patent/EA201691232A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Настоящим изобретением обеспечиваются композиции и способы, применимые для лечения и предупреждения нейродегенеративного заболевания и неврологически родственных нарушений путем ингибирования Lp-PLA. Композиции и способы применимы для лечения и предупреждения заболеваний и нарушений, связанных с нарушенным функционированием гематоэнцефалического барьера (ВВВ), например нейродегенеративных заболеваний с проницаемым ВВВ, таких как, но без ограничения, болезнь Альцгеймера, болезнь Хантингтона, болезнь Паркинсона и сосудистая деменция.The present invention provides compositions and methods applicable to the treatment and prevention of neurodegenerative disease and neurologically related disorders by inhibiting Lp-PLA. Compositions and methods are applicable to the treatment and prevention of diseases and disorders associated with impaired blood-brain barrier (BBB), such as neurodegenerative diseases with permeable BBB, such as, but without limitation, Alzheimer's disease, Huntington's disease, Parkinson's disease and vascular dementia.

EA201691232A 2007-05-11 2007-05-11 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS EA201691232A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201691232A EA201691232A1 (en) 2007-05-11 2007-05-11 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201691232A EA201691232A1 (en) 2007-05-11 2007-05-11 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS

Publications (1)

Publication Number Publication Date
EA201691232A1 true EA201691232A1 (en) 2017-01-30

Family

ID=57881899

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691232A EA201691232A1 (en) 2007-05-11 2007-05-11 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS

Country Status (1)

Country Link
EA (1) EA201691232A1 (en)

Similar Documents

Publication Publication Date Title
EA200971050A1 (en) METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS
EA200901032A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA200901166A1 (en) CONNECTIONS AND COMPOSITIONS AS GPR 119 ACTIVITY MODULATORS
EA201100138A1 (en) 4-PHENOXYMETHYL-PIPERIDINES AS MODEL ACTIVITY GPR119
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
EA200970337A1 (en) SODIUM-GLUCOSE 2 COPHANTER OF INHIBITORS AND METHODS OF THEIR APPLICATION
EA201270480A1 (en) NEW CONNECTIONS
WO2013033037A3 (en) Novel antiprion compounds
EA201071243A1 (en) COMBINED COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISEASES WITH ZONISSMID AND ACAPROSAT
EA200900178A1 (en) Condensed Heterocyclic Derivatives and Their Application
EA201200570A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
UA103930C2 (en) Normal;heading 1;heading 2;heading 3;COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF PARASITIC DISEASES
EA201690787A1 (en) CONNECTIONS AND THEIR APPLICATION AS BETA SITE APP (BACE) ENZYME INHIBITORS
EA200700909A1 (en) AZAINDOLKARBOXAMIDES
DOP2007000053A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
ATE478863T1 (en) HETEROTETRACYCLIC COMPOUNDS AS TPOMIMETICA
EA201291413A1 (en) DERIVATIVES 3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-SHE, APPLICABLE FOR THE TREATMENT OF ALCHEIMER'S Disease And Other Forms Of Dementia
WO2010059241A3 (en) Treatment of amyotrophic lateral sclerosis
EA200900783A1 (en) COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
WO2010075280A3 (en) Coumarin-based compounds for the treatment of alzheimer's disease and cancer
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
MX2009005351A (en) Compounds useful for treating neurodegenerative disorders.
EA200801302A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF CNS DISORDERS
EA201001586A1 (en) COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
EA201170421A1 (en) N-SULPHONAMIDOPYRAZOLYL POLYCYCLIC COMPOUNDS